Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron isomaltoside vs iron polysaccharide for iron deficiency anemia after bariatric surgery
ChiCTR2400083168Phase 4Not yet recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Apr 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of ferric derisomaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Third People's Hospital of Chengdu. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2400083168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083168.